Suppr超能文献

米非司酮与吉美前列素用于终止孕中期妊娠:197例连续病例的临床经验

Termination of second trimester pregnancy with mifepristone and gemeprost. The clinical experience of 197 consecutive cases.

作者信息

Gemzell-Danielsson K, Ostlund E

机构信息

Department of Woman and Child Health, Karolinska Hospital, Stockholm, Sweden.

出版信息

Acta Obstet Gynecol Scand. 2000 Aug;79(8):702-6.

Abstract

BACKGROUND

Earlier controlled clinical trials have demonstrated that combined treatment with the antiprogestagen, mifepristone and a suitable prostaglandin reduce the induction to abortion time in second trimester abortion. The aim of this study was to describe the results of the 197 consecutive second trimester terminations performed in routine clinical practice at our Department from 1996 to 1998.

METHODS

The report is based on 197 consecutive second trimester abortions including live pregnancies and missed abortions, carried out in 192 women. The women were treated with 600 mg mifepristone followed 24 to 48 hours later by 1 mg gemeprost administered every 6 hours four times. If abortion had not occurred, 1 mg gemeprost was administered every 3 hours for the next 12 hours. After expulsion of the fetus a surgical evacuation of the uterus was routinely performed up to 18 weeks gestation and thereafter when needed. The induction to abortion time was defined as the interval between the insertion of the first gemeprost pessary and expulsion of the fetus.

RESULTS

The median abortion time was 9.0 (1.4-40.5) hours for primigravidae and 7.2 (0-152.5) hours for multigravidae. The medium number of gemeprost pessaries to induce abortion was two and all except seven women aborted within 24 hours. Significantly more abortions occurred before 6, 7 and 8 hours in multigravidae than among primigravidae. The induction to abortion interval was also significantly shorter for nulliparous than for parous women. Except for one case of heavy bleeding, no serious complications occurred.

CONCLUSION

The study confirms the efficacy and safety of mifepristone, together with gemeprost, for termination of second trimester pregnancy when routinely used in the clinic.

摘要

背景

早期的对照临床试验表明,抗孕激素米非司酮与合适的前列腺素联合治疗可缩短中期妊娠流产的引产时间。本研究的目的是描述1996年至1998年在我们科室常规临床实践中连续进行的197例中期妊娠终止的结果。

方法

本报告基于197例连续的中期妊娠流产,包括活胎妊娠和稽留流产,涉及192名妇女。这些妇女先服用600毫克米非司酮,24至48小时后每6小时服用1毫克吉美前列素,共服用4次。如果流产未发生,则在接下来的12小时内每3小时服用1毫克吉美前列素。胎儿排出后,妊娠18周及以内常规进行清宫手术,之后根据需要进行。引产时间定义为首次放置吉美前列素阴道栓至胎儿排出的间隔时间。

结果

初产妇的中位流产时间为9.0(1.4 - 40.5)小时,经产妇为7.2(0 - 152.5)小时。引产所需吉美前列素阴道栓的中位数为2个,除7名妇女外,所有妇女均在24小时内流产。经产妇在6、7和8小时之前发生流产的人数明显多于初产妇。未生育妇女的引产间隔时间也明显短于经产妇。除1例大出血外,未发生严重并发症。

结论

该研究证实了米非司酮与吉美前列素联合用于临床中期妊娠终止时的有效性和安全性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验